InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+57.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Thistle Mary, Director. Officer active across 3 companies, notably Ziopharm Oncology INC. Cumulatively, 5 reports have been recorded. History available since 4 March 2021. The latest transaction was disclosed on 22 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations5 total
5,000 shares0Common StockSEC:0000950170-25-077267:0
40,000 shares0Common StockSEC:0000899243-22-024011:0
40,000 shares0Common StockSEC:0000899243-22-023997:0
5,000 shares0Common StockSEC:0001209191-21-030743:0
5,000 shares0Common StockSEC:0001209191-21-030743
5 of 5 declarations
About Thistle Mary
Mary Thistle is a Director at ZIOPHARM Oncology Inc and Alaunos Therapeutics, Inc. In this role, she provides expertise in strategy and corporate governance. Thistle plays a key role in performance assessment and strategic decision-making within the boards. Her experience in the biotechnology sector is an asset to the companies she serves.
